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Abstract
Background: Norovirus is a common cause of infectious gastrointestinal disease. Despite the increased ability to
detect norovirus in affected people, the number of reported cases and outbreaks in the community is still substantially
underestimated. We undertook a systematic review to determine the nature, scope and scale of community-based
surveillance systems which capture information on norovirus disease.
Methods: We searched MEDLINE, EMBASE and Scopus for studies published between 01 January 1995 and 31 December
2015, using terms relating to norovirus and surveillance. Publications were screened independently by two reviewers
using exclusion criteria. Data extraction from included papers was performed using a standardized data extraction form.
Outcomes were descriptions of the methods reported in included papers, and any estimates of incidence rate of
norovirus disease in each community, stratified by age.
Results: After exclusions, we reviewed 45 papers of which 23 described surveillance studies and 19 included estimates of
incidence. The estimates of incidence varied by outcome measure, type of laboratory test and study population. There
were two estimates of norovirus hospitalisation; 0.72 and 1.04 per 1000 person-years. Estimates of norovirus disease
ranged between 0.024 cases per 1000 person-years and 60 cases per 1000 person-years and estimates of all
gastroenteritis varied between 49 and 1100 cases per 1000 person-years.
Conclusions: Our systematic review found few papers describing community-based surveillance for norovirus disease.
Standardised age-specific estimates of norovirus incidence would be valuable for calculating the true global burden of
norovirus disease; robust community surveillance systems would be able to produce this information.
Trial Registration: PROSPERO 2016:CRD42016048659.
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Background
Norovirus infection is the most common cause of infec-
tious gastrointestinal disease in the United Kingdom
(UK) and many other countries [1, 2]. Globally, it is
estimated to be associated with 18% of all cases of acute
gastroenteritis [3]. Norovirus is a common cause of
gastroenteritis outbreaks in healthcare settings [4]. Out-
breaks are difficult to control in enclosed settings and
the evidence for the effectiveness of infection control
methods remains inconclusive [5, 6]. The infection is
typically mild and self-limiting and people who are
infected rarely have contact with medical services;
further detail on the clinical manifestations of norovirus
has been described elsewhere [1]. Some groups, particu-
larly the elderly, can have longer episodes of illness [7],
and are at risk of more serious outcomes [8].
Surveillance of norovirus disease is essential for provid-
ing information for norovirus prevention and control [9].
Different types of surveillance system are used and have
been described elsewhere [5]. Norovirus surveillance is
largely based on laboratory diagnosis and the ability to
detect norovirus in affected people has increased with the
adoption of more sensitive molecular methods [10]. There
is evidence that the number of reported cases and
outbreaks in the community is substantially underesti-
mated; and that this underestimation is greater in the
community than hospital settings [5, 11, 12], but there is
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little evidence of the type and variety of community-based
norovirus surveillance systems. We were prompted to
undertake this research to address this gap.
The aim of this research is to determine the nature,
scope and scale of community-based surveillance
systems which capture information on norovirus disease.
To do this, we undertook a systematic review according
to the criteria of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) state-
ment [13]. In order to determine the nature, scope and
scale of community-based surveillance of norovirus
disease, we described the methods reported in papers in-
cluded in the review, as a primary objective. A secondary
objective was to capture the incidence rate of norovirus
disease in each setting.
Methods
Protocol and registration
The review was registered on the PROSPERO Inter-
national prospective register of systematic reviews on 03
October 2016 (PROSPERO 2016:CRD42016048659)
[14]. The review protocol followed the PRISMA check-
list (Additional file 1).
Eligibility criteria
Studies published between 01 January 1995 and 31
December 2015. No explicit geographical restrictions
were applied. Only studies published in English were
eligible. We excluded the following types of publication:
studies of illness in persons residing in primary care
settings, reports or reviews of outbreak investigations,
review papers, editorials, conference abstracts or pro-
ceedings, randomized clinical trials or case reports,
environmental surveillance, economic analyses, studies
based on asymptomatic infections, surveys of molecular
epidemiology or seroprevalence surveys.
Information sources
We searched the following electronic databases: MEDLINE,
EMBASE and Scopus. The last date searched was 16
August 2016.
Search
We used the following search terms: (norovirus.ab,ti. OR
(norwalk-like adj1 virus).ab,ti. OR (norwalk-like adj1 dis-
ease*).ab,ti. OR norwalk.ab,ti. OR small round structured
virus.ab,ti. OR winter vomiting disease.ab,ti.) AND
surveillance.ab,ti. The search terms were piloted prior to
selection and are comprised of specific norovirus terms.
The search terms for MEDLINE were developed initially.
Terms were combined using Boolean operators. The
same terms were used to search Scopus. When the
searches were run in MEDLINE, each term was searched
for within the title and abstract of the documents
contained in each database; in Scopus, terms were
searched within the title, abstract and keywords.
Study selection
All references identified by the search strategy were
imported into the reference management programme
EndNote X7 (Clarivate Analytics, USA). Using this soft-
ware, publications from the different databases were com-
bined and deduplicated. These publications were then
screened applying the exclusion criteria. This screening
was conducted independently by two reviewers (TI and
JPH) to ensure the criteria were applied consistently. Dif-
ferences between reviewers on first screening were recon-
ciled by discussion between the two reviewers. Full texts
of all studies meeting the title and abstract screening cri-
teria were examined independently by the two reviewers
(TI and JPH) using a standardised eligibility form. Final
agreement on study inclusion was determined through
consensus between the two reviewers (TI and JPH).
In order to maximise the proportion of eligible studies in-
cluded in the review, the reference lists of studies that met
the inclusion criteria were searched to identify potentially
relevant articles not included be the database searches.
When potentially relevant articles were identified in this
way, the two reviewers (TI and JPH) searched for abstracts
and then screened in the same fashion as those identified
by the database search. The full text of any abstract that
met the eligibility criteria was assessed using the standar-
dised eligibility form; final agreement was determined
through consensus between the two reviewers.
Data collection process and data items
Data extraction from included papers was performed
using a standardized data extraction form. The following
data were extracted (where available): year published,
predominant study type, surveillance type (active or
passive), study setting, time period, study duration, geog-
raphy (country, region), case definition, laboratory
testing methods, proportion of norovirus detections, use
of further typing methods, population age range, study
population, person-time of study population, number of
cases, incidence rate with 95% Confidence Interval. We
defined the surveillance type as active if the person-time
at risk was actively enumerated.
Summary measures
Outcomes were descriptions of the methods reported in
included papers, and any estimates of incidence rate of nor-
ovirus disease in each community, stratified by age. Esti-
mates of incidence rates were not pooled between studies.
Synthesis of results
We compared methods used in included papers. We
described the study design and methods used, the
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population under surveillance, the date of publication,
the location of study and compared incidence rates in
various studies, stratified by age where available.
Results
Study selection
The first searches identified 1058 papers; following de-
duplication this was reduced to 673 publications. After
review of the title and abstract, 56 publications were in-
cluded and 617 excluded. Of the 56 publications subject
to full text review, 11 were excluded and 45 included in
this systematic review (Fig. 1). Of the 11 papers excluded
after full text review, seven were conference proceedings,
two were non-English language, one was an economic
analysis and one was a survey of molecular epidemiology.
Characteristics of included studies
The number of publications regarding the community-
based surveillance of norovirus disease increased over
the 20 year period included in this review; two thirds of
papers (n = 30) were published since 2010. Papers based
in community settings in Europe (n = 20) were most
frequent, the majority of these being from the United
Kingdom (n = 7) and France (n = 4). Other countries
with multiple published studies include the United
States of America (n = 6), Australia (n = 3) and China
(n = 3). Figure 2 shows the distribution of publications
over time and by geography of study location.
A total of 23 publications described surveillance
studies; 18 of these described surveillance of individuals, five
described surveillance of norovirus outbreaks in the com-
munity. Other community-based publications included co-
hort studies (n = 14), cross-sectional surveys (n = 7) and
one case–control study in a community setting. A break-
down of included publications by study type is shown in
Table 1.
Description of methods reported in community-based
norovirus surveillance.
Reports of community-based surveillance of laboratory
reports of norovirus infection were published from
England and Wales [15–17], Germany [18] and the United
States of America (USA) [19]. Surveillance using sentinel
general practitioners (family doctors) was reported from
France [20]. Surveillance of norovirus using a foodborne
illness complaint system in the USA state of Minnesota
[21]. Reports of the surveillance of norovirus outbreaks in
the community were published from the USA [22, 23].
Norovirus outbreak surveillance in care homes was re-
ported from France [24–26] and Australia [27].
A number of papers described the surveillance of cases
of norovirus acquired in the community, through the
surveillance of cases admitted to hospital from the com-
munity. Sentinel networks or small groups of hospitals
published their findings from Japan [28, 29], Israel [30],
USA [31] and Bangladesh [32]. Four publications
reported surveillance at individual hospitals in China
[33, 34], Poland [35] and Malawi [36]. Children under
five years old were included in one case–control study
in Colombia [37]. A total of 20 papers were classed as
active surveillance and 25 were classed as passive
surveillance.
Cohort studies captured surveillance data on norovirus
disease in children in general practice [38–40], in day
care [41] and in hospital [42–44]. Two birth cohort
studies, one in Vietnam [45] and one across eight sites
in South America, Africa and Asia [46]. Four cohort
studies captured surveillance data on norovirus disease
in all of those attending general practice [11, 47–49];
one cohort study was based in 16 care homes [50] and
one a cohort study of military personnel [51]. A number
of cross-sectional studies from different countries col-
lected information on the general population [52–56].
One study was of hospitalised children [57] and another
included hospital outpatients [58].
Of the 39 papers which covered the surveillance of in-
dividual cases, all but one used a laboratory test to
confirm the presence of norovirus. Polymerase chain re-
action (PCR) was used either alone or in combination
with other methods by 29 of the reports; enzyme
immunoassay (EIA) was used as the only method in two
studies and electron microscopy (EM) as the only
method in one study. The laboratory methods were
either absent or unclearly defined in five studies. The
case definition was based on the WHO definition of
Fig. 1 Study selection, systematic review of community-based
surveillance of norovirus disease (n = 1058)
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diarrhoea in 22 of the 39 studies; another symptomatic
definition was used in 13 of the studies, one study used
a virological case definition and the case definition was
unclear in the remaining three studies. Regarding the
surveillance of norovirus outbreaks, three of the six used
the Centres for Disease Control and Prevention (CDC)
outbreak definition [22, 23, 27]. Comparable definitions
were used by the other three studies [24–26]. All noro-
virus outbreak surveillance systems used some form of
laboratory confirmation; PCR was used alone or in com-
bination for five studies, the lab method wasn’t specified
in the other study.
Estimates of the incidence rate of norovirus disease in
each community
Publications included in this review measured outcomes
that can be classified into three groups; norovirus hospi-
talisation, norovirus disease and all gastroenteritis. A
total of 19 papers included estimates of incidence, of
which seven also published Confidence Intervals.
Figure 3 depicts the estimated incidence rates by out-
come and study age group. Of the 19 papers, 14 were
classed as active surveillance and clearly enumerated the
person-time at risk.
Two papers used norovirus hospitalisation as an out-
come, both were based in those aged under five and
reported similar estimates; 0.72 [31] and 1.04 [30]
hospitalisations per 1000 person-years. Six papers pro-
vided estimates of norovirus disease incidence. Esti-
mates of norovirus disease ranged between 0.024
cases per 1000 person-years and 60 cases per 1000
person-years [11, 15, 18, 47, 51, 56].
Incidence rates of all gastroenteritis were estimated by
14 papers. Estimates in children under five ranged
between 29.5 and 389 cases per 1000 person-years
[35, 38, 40, 41, 45]. Estimates in all ages ranged
between 49 and 1100 cases per 1000 person-years [11, 47,
49, 52–55]. One paper estimated the incidence rate of all
gastroenteritis in long-term care facility (LTCF) resident
as 0.64 cases per 1000 bed-days [50]. Another estimated
the incidence rate of gastroenteritis outbreaks in LTCFs as
16.8 per 100 LTCFs per year [27].
Discussion
Our systematic review has found few papers describing
community-based surveillance for norovirus disease. We
found surveillance based on individual laboratory reports
were reported from four countries; England and Wales,
Germany, France and the USA. Surveillance of outbreaks
in care homes was reported from France and Australia.
We found a number of hospital-based surveillance
reports capturing illness acquired in the community;
these tended to be based in a single or small number of
hospitals and many were cross-sectional or cohort
studies in a fixed time period. Several papers from the
USA reported on the surveillance of outbreaks associ-
ated with food.
The small number of national surveillance systems
reporting norovirus disease is likely to be related to the
knowledge that most people do not access health care
for a diagnosis [11]. One explanation could be the lack
of statutory basis for norovirus reporting. The European
Surveillance System (TESSy) is a system used by
7European Union (EU) Member States and European
Fig. 2 Reviewed studies; shown by year of publication and geography of study location (n = 44*). *One study published in 2015 was based in
several sites across the world
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Economic Area (EEA) countries for the collection, ana-
lysis and dissemination of data on communicable
diseases. Norovirus disease is not one of the 52 commu-
nicable diseases covered by this surveillance system [59].
Another reason could be the low priority of testing for
norovirus with limited healthcare or laboratory re-
sources. Due to the usually mild self-limiting nature of
the disease, testing for norovirus may not be prioritised
by healthcare providers. This is an issue in high-resource
countries, but is particularly relevant in low-resource
settings. This under-representation of developing coun-
tries may be partially addressed by plans for the inclu-
sion of norovirus in the World Health Organisation
(WHO) global rotavirus surveillance network [60], which
includes a number of developing countries. The change
in the number of papers published, whereby we
observed that the majority have been published since
2010, is likely to be related to the change in testing from
electron microscopy to more rapid and more sensitive
techniques such as real-time polymerase chain reaction
(RT-PCR) and EIA [61].
We found that estimates of the incidence rate of
community-based norovirus disease had three outcome
measures; norovirus hospitalisation, norovirus disease
and all gastroenteritis. The two estimates of norovirus
hospitalisation in children were both similar, around one
case per 1000 person-years. Of the estimates of noro-
virus disease, one estimate was far lower (0.024 cases per
1000 person-years) than the others [15]. This much
lower estimate is possibly due to the different diagnostic
methods used; this is the earliest published study
included in the review and at that time diagnosis of
norovirus was by electron microscopy which is far less
sensitive for detecting norovirus. This may also reflect
changes in the criteria for testing for norovirus; as
cheaper PCR tests have become more widespread, this
may have led laboratories to widen the criteria for test-
ing stool specimens for norovirus. The wide range of
other estimates for norovirus disease (12.5–60 cases per
1000 person-years) and all gastroenteritis (29.5–1100
cases per 1000 person-years) probably reflects the differ-
ent populations and age groups included. Unfortunately
12 of the publications included a point estimate, but did
not include any estimate interval. Therefore, caution
must be used when drawing conclusions from the differ-
ing estimates.
Subsequent to the period of this literature search, a
report has been published on an enhanced surveillance
system for norovirus in an area of China [62]. The rate
of norovirus-associated diarrhoea that they observed was
Fig. 3 Studies with estimates of community incidence, shown by measured outcome and population age group (n = 19). *No published Confidence
Interval estimate; (a) population under 1; (b) 6 months to 3 years old; (c) males aged 18 to 34
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89 cases per 1000 person-years (95% CI 82–97); this is
higher than any of the estimates captured in this review,
the next highest being 60 cases per 1000 person-years
from a study in South America [51]. This higher rate in
China may represent an increased incidence in this
population, or could be a product of the extrapolations
used to produce the estimate from the surveillance data.
In this review we were only able to include papers
written in English due to resource limitations. As a
consequence of not including those publications not in
English, it is likely that we have under-represented the
findings of countries where English is not widely spoken.
In addition, some reports or descriptions of surveillance
systems may be published on institute websites rather
than indexed journals. This type of “grey literature” is
difficult to search and capture in a systematic way, so is
therefore excluded from this review, possibly affecting
the representativeness of our findings. We were not able
to undertake a meta-analysis of the norovirus incidence
rates due to the extensive heterogeneity in study designs,
laboratory methods, outcome measures and study popu-
lations. A meta-analysis to estimate the prevalence of
norovirus in persons with acute gastroenteritis has previ-
ously been conducted [3].
Of the 45 publications included in this review, inci-
dence estimates were only available for 19. Excluding
those publications reporting on the surveillance of out-
breaks, 20 publications did not include an estimate of in-
cidence. Of the 19 papers reporting incidence estimates,
14 were classed as active surveillance as they clearly
enumerated the person-time at risk in the population.
The five papers classed as passive surveillance used
population denominators which assume that all persons
would have been captured in the surveillance system
had they become a case. It has been shown that a large
proportion of norovirus cases are not captured in
national surveillance systems [11], so estimates from
these passive systems have to be interpreted in this light.
A number of the surveillance publications, particularly
those based in hospitals, did not report or estimate a
denominator population. Without a population denom-
inator, it is not possible to calculate incidence rates. We
would recommend that future publications of this kind
include an estimate of the population denominator as
good epidemiological practice, and to facilitate further
research of this kind.
Conclusions
In this systematic review, we found that despite noro-
virus being an important cause of acute gastroenteritis,
in terms of number of cases that occur, few papers
describe community-based surveillance for it, and a
small number report any measure of norovirus inci-
dence. Standardised age-specific estimates of norovirus
incidence would be valuable for calculating the true glo-
bal burden of norovirus disease; robust community sur-
veillance systems would be able to produce this
information.
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